Φορτώνει......
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has not only distressed medical services but also caused economic upheavals, marking urgent the need for effective therapeutics. The experie...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Enzyme Inhib Med Chem |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7808739/ https://ncbi.nlm.nih.gov/pubmed/33430659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1850710 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|